-+ 0.00%
-+ 0.00%
-+ 0.00%

PSYENCE BIOMED ANNOUNCES APPROVAL FOR USE OF PSYLABS’ PSILOCYBIN PRODUCT IN PHASE IIB CLINICAL TRIAL

路透·12/19/2025 12:00:00

登录查看新闻详情